Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Larijani, Bagher  [Clear All Filters]
Journal Article
Ghomi MKhalili, Noori M, Montazer MNazari, Zomorodian K, Dastyafteh N, Yazdanpanah S, Sayahi MHosein, Javanshir S, Nouri A, Asadi M, et al. [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies. Sci Rep. 2023;13(1):10136.
Nomali M, Amini MReza, Aalaa M, Sanjari M, Mohajeri-Tehrani MReza, Adibi H, Yarahmadi M, Alijani N, Saeidi H, Molavi B, et al. Adoption of IWGDF guidance on prevention and management of foot problems in diabetes for local use in Iran by ADAPTE methodology: a step toward best practice. J Diabetes Metab Disord. 2023;22(1):245-254.
Larijani B, Aghayan H, Goodarzi P, Mohamadi-Jahani F, Norouzi-Javidan A, Dehpour AReza, Fallahzadeh K, Sayahpour FAzam, Bidaki K, Arjmand B. Clinical Grade Human Adipose Tissue-Derived Mesenchymal Stem Cell Banking. Acta Med Iran. 2015;53(9):540-6.
Hamidieh AAli, Mohajeri-Tehrani MReza, Behfar M, Vaghari-Meher N, Alimoghaddam K, Mohseni F, Ghavamzadeh A, Larijani B, Hamidi Z. Comparison of Bone Mineral Density Changes in Pediatric Thalassemic Patients With and Without Hematopoietic Stem Cell Transplant. Exp Clin Transplant. 2014.
Arjmand B, Alavi-Moghadam S, Sarvari M, Rezaei-Tavirani M, Rezazadeh-Mafi A, Arjmand R, Nikandish M, Nasli-Esfahani E, Larijani B. Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells. Inflammopharmacology. 2023.
Niri DRezapour, Sayahi MHosein, Behrouz S, Moazzam A, Rasekh F, Tanideh N, Irajie C, Nezhad MSeif, Larijani B, Iraji A, et al. Design, synthesis, , and evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors. Heliyon. 2023;9(11):e22009.
Arjmand B, Alavi-Moghadam S, Kokabi-Hamidpour S, Arjmand R, Rezaei-Tavirani M, Larijani B, Goodarzi P, Mehrdad N, Rajaeinejad M. Development and Validation of Type 2 Diabetic Zebrafish Model for Cell-Based Treatments. Methods Mol Biol. 2023.
Tayanloo-Beik A, Hamidpour SKokabi, Nikkhah A, Arjmand R, Mafi ARezazadeh, Rezaei-Tavirani M, Larijani B, Gilany K, Arjmand B. DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game. Adv Exp Med Biol. 2023.
Alizadeh N, Sayahi MHossein, Iraji A, Yazzaf R, Moazzam A, Mobaraki K, Adib M, Attarroshan M, Larijani B, Rastegar H, et al. Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors. Bioorg Chem. 2022;126:105876.
Ghomi MKhalili, Noori M, Mirahmad M, Iraji A, Sadr AShahir, Dastyafteh N, Asili P, Gholami M, Javanshir S, Lotfi M, et al. Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties. Eur J Med Chem. 2024;269:116332.
Hamidieh AA, Hamidi Z, Behfar M, Pajouhi Z, Alimoghaddam K, Mohseni F, Ghavamzadeh A, Sobhani M, Larijani B, Tehrani MRMohajeri. How is the relation between endocrine changes and bone markers in pediatric thalassemic patients after Hematopoietic Stem Cell Transplantation. Minerva Pediatr. 2016.
Arjmand B, Bahrami-Vahdat E, Alavi-Moghadam S, Arjmand R, Rezaei-Tavirani M, Namazi N, Larijani B. Human-Induced Pluripotent Stem Cell‒Derived Keratinocytes, as Therapeutic Option in Vitiligo. Methods Mol Biol. 2024.
Arjmand B, Hamidpour SKokabi, Tayanloo-Beik A, Arjmand R, Rezaei-Tavirani M, Namazi N, Ojagh H, Larijani B. Incorporating NK Cells in a Three-Dimensional Organotypic Culture System for Human Skin Stem Cells: Modeling Skin Diseases and Immune Cell Interplay. Methods Mol Biol. 2023.
Peykari N, Mehdipour P, Larijani B, Sepanlou SG, Djalalinia S, Kasaeian A, Parsaeian M, Ahmadvand A, Khosravi A, Malekzadeh R, et al. The levels and trends of diabetes prevalence at national and sub-national levels in Iran (1990 - 2016). J Diabetes Metab Disord. 2023;22(1):743-752.
Aghayan HReza, Soleimani M, Goodarzi P, Norouzi-Javidan A, Emami-Razavi SHasan, Larijani B, Arjmand B. Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci. 2014;19(5):465-71.
Dastyafteh N, Noori M, Montazer MNazari, Zomorodian K, Yazdanpanah S, Iraji A, Ghomi MKhalili, Javanshir S, Asadi M, Dianatpour M, et al. New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation. Sci Rep. 2023;13(1):21.
Asadi M, Fayazi F, Iraji A, Sabourian R, Azizian H, Hajimahmoodi M, Larijani B, Mahdavi M, Amanlou M. Nitrophenylpiperazine derivatives as novel tyrosinase inhibitors: design, synthesis, and in silico evaluations. BMC Chem. 2024;18(1):67.
Noori M, Dastyafteh N, Safapoor S, Ghomi MKhalili, Tanideh R, Zomorian K, Hamedifar H, Dara M, Zare S, Irajie C, et al. Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3β level targeting Alzheimer's disease. Int J Biol Macromol. 2023:127392.
Arjmand B, Alavi-Moghadam S, Kokabi-Hamidpour S, Arjmand R, Rezaei-Tavirani M, Larijani B. Preparation and Validation of Zebrafish Psoriasis Model to Investigate the Therapeutic Effects of Stem Cells. Methods Mol Biol. 2023.
Hajimiri M, Khosravikia M, Khoshneviszadeh M, Pedrood K, Hosseini SZahra, Asgari MSadegh, Pirhadi S, Attarroshan M, Mobaraki K, Hosseini S, et al. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors. Chem Biodivers. 2022:e202100964.
Adibi H, Arjmand B, Aghayan HReza, Bahrami-Vahdat E, Alavi-Moghadam S, Rezaei-Tavirani M, Arjmand R, Namazi N, Larijani B. Standardized GMP-Compliant Scalable 3D-Bioprocessing of Epidermal Stem Cells for Diabetic Foot Ulcers. Methods Mol Biol. 2024.
Goodarzi P, Aghayan H, Soleimani M, Norouzi-Javidan A, Mohamadi-Jahani F, Jahangiri S, Emami-Razavi SHasan, Larijani B, Arjmand B. Stem Cell Therapy for Treatment of Epilepsy. Acta Med Iran. 2014;52(9):651-655.
Larijani B, Roudsari PParhizkar, Hadavandkhani M, Alavi-Moghadam S, Rezaei-Tavirani M, Goodarzi P, Sayahpour FAzam, Mohamadi-Jahani F, Arjmand B. Stem cell-based models and therapies: a key approach into schizophrenia treatment. Cell Tissue Bank. 2021.
Hashemi A, Noori M, Dastyafteh N, Sadat-Ebrahimi SEsmaeil, Haghighi NFazelzadeh, Mehrpour K, Sattarinezhad E, Zafrei FJalali, Irajie C, Daneshmehr MAli, et al. Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones. BMC Chem. 2023;17(1):65.
Forozan RD, Ghomi MKhalili, Iraji A, Montazer MNazari, Noori M, Dastyafteh N, Mojtabavi S, Faramarzi MAli, Sadat-Ebrahimi SEsmaeil, Larijani B, et al. Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors. Sci Rep. 2023;13(1):7819.

Pages